We are proud to announce that Yana Yaroshevska, attorney at Doubinsky & Osharova, has published an in-depth article in Yurydychna Gazeta titled "Protection of Pharmaceutical Innovations in Ukraine: Trends, Opportunities and Challenges."
In her article, Yana provides a comprehensive overview of how pharmaceutical innovations can drive Ukraine’s economic recovery amid the challenges of wartime and limited material resources. Drawing on global innovation indicators from the World Economic Forum’s Future of Growth 2024 Report, she underscores Ukraine’s untapped innovative potential and the strategic importance of the pharmaceutical industry, which accounted for 1.6% of Ukraine's industrial output in 2023.
The article explores key market trends, including the growth of e-commerce, expansion of exports, rising popularity of dietary supplements, and ongoing legislative reforms aligned with EU integration. Yana also analyzes the WINWIN Strategy for digital innovation, highlighting specific goals for the MedTech and BioTech sectors — such as streamlining drug registration procedures, fostering public-private partnerships, and enabling participation in EU R&D programs.
Yana offers expert commentary on recent and proposed legislative initiatives, including:
- Amendments related to the “Bolar Exception”;
- Parallel import of pharmaceuticals;
- The evolving regulation of intellectual property rights under martial law;
- Implementation of the updated Law of Ukraine "On Medicinal Products."
Her article is a must-read for legal and pharmaceutical professionals seeking insight into Ukraine’s dynamic innovation landscape and its legal implications.
Read the full article (in Ukrainian here): https://drive.google.com/file/d/19-8saGuKFZtPFZR01zE6tbIu8EiOP0_k/view?usp=sharing